General Principles - The management system for changes in shareholding by directors and senior management of Guangdong Leshi Medical Electronics Co., Ltd. aims to enhance the management of shareholding changes and clarify procedures for information disclosure [1][2] - This system applies to all shares held by directors and senior management, including those held through third-party accounts [1][2] Information Reporting and Disclosure - The board office is responsible for managing the identity and shareholding data of directors and senior management, ensuring timely online reporting and regular checks on share trading disclosures [2][3] - Directors and senior management must report their personal identity information to the Shenzhen Stock Exchange within two trading days after their appointment or any changes [2][3] Trading Procedures - Directors and senior management must notify the board secretary in writing of their trading plans before buying or selling shares, and the board secretary must verify compliance with disclosure and legal requirements [4][5] - If shareholding changes occur, they must be reported to the company within two trading days and disclosed on the Shenzhen Stock Exchange [5][6] Shareholding Change Management - Certain conditions restrict the transfer of shares held by directors and senior management, such as within one year of the company's stock listing or within six months after leaving their position [6][7] - Directors and senior management are prohibited from trading shares during specific periods, such as 15 days before annual or semi-annual reports [6][7] Accountability - Any violations of the trading regulations by directors and senior management will result in the company reclaiming any profits made from such trades [8][9] - The company will impose penalties for violations, which may include warnings, demotions, or termination of employment [9][10] Additional Provisions - Shareholders holding more than 5% of the company's shares must adhere to the same regulations as directors and senior management [10][11] - The system will be effective upon approval by the board and will be subject to relevant laws and regulations [11]
乐心医疗: 董事、高级管理人员持股变动管理制度(2025年05月)